2022 West Oncology Conference
Avatar

Early Breast Cancer: Current Systemic Treatment Approaches

By 2022 West Oncology Conference FEATURING Lee Schwartzberg
March 14, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

17:04
Novartis Oncology

Discussion on Overall Survival Data Across 3 Phase III Trials in HR+…

Feat. G. Hortobagyi

Featured Video

18:15
Novartis Oncology

CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…

Feat. G. Hortobagyi

Related Content

AUTOPLAY
28:34
Breast Health Global Initiative

Clinical Pathways for Early Diagnosis of Breast Cancer

27:39
Breast Health Global Initiative

Metastatic Breast Disease: Treatment and Palliative Care

Feat. A. Eniu
26:31
Yale Cancer Center

The Myth of Early Detection of Breast Cancer

Feat. D. Lannin
30:05
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor Positive Advanced Breast Cancer Case 1: Management …

Feat. J. Abraham, R. Finn, M. Dickler
14:37
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 2: Patient with…

Feat. J. Abraham
18:34
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Positive Advanced Breast Cancer: Case 3: Treatment …

Feat. J. Abraham, R. Finn, M. Dickler
11:40
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 4: Patient with…

Feat. J. Abraham, R. Finn, M. Dickler
16:44
Heather McArthur

Modern Immune Therapy Strategies for Triple-Negative Breast Cancer

17:54
Heather McArthur

Modern Immune Therapy in ER, HR+/HER2-, HER2+ Breast Cancer

24:03
Holy Cross 9th Annual Winter Oncology Symposium

Early Stage Breast Cancer - Comparison of Trials of Genomic Assays -…

Feat. R. L. Mahtani
07:43
Dana-Farber Cancer Institute

Study of Abemaciclib for Patients with RB-Positive, Triple Negative …

Feat. S. Goel
24:33
Holy Cross 9th Annual Winter Oncology Symposium

Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratini…

Feat. B. Moy
12:05
Holy Cross 9th Annual Winter Oncology Symposium

Future Directions in the Targeting of HER2+ Breast Cancer: duration …

Feat. B. Moy
12:44
Holy Cross 9th Annual Winter Oncology Symposium

Emerging Targets in ER Positive Breast Cancer: CDK4/6 inhibitors, Bc…

Feat. M. Abu-Khalaf
10:12
Holy Cross 9th Annual Winter Oncology Symposium

Emerging Targets in HER-2 Negative, TNBC and HER-3 Positive Breast C…

Feat. M. Abu-Khalaf
32:33
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Adjuvant Chemotherapy for HR+/HER2- Breast Cancer - How MINDACT, TAI…

Feat. L. Carey
11:57
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

HR+/HER2- Breast Cancer - Who Needs Extended Adjuvant Endocrine Ther…

Feat. L. Carey
07:58
Sandra Swain

ASCO 2019 End-of-study Survival Analysis from the Cleopatra Study Sh…

18:15
Baltic and Eurasia Masterclass in Clinical Oncology

Systemic Therapy for Early Breast Cancer: Treatment Strategies for P…

Feat. O. Pagani
11:07
Baltic and Eurasia Masterclass in Clinical Oncology

Advanced Breast Cancer: Endocrine Therapy as Preferred Option for HR…

Feat. O. Pagani